ZORODDU, STEFANO

ZORODDU, STEFANO  

Mostra records
Risultati 1 - 5 di 5 (tempo di esecuzione: 0.004 secondi).
Titolo Data di pubblicazione Autore(i) File
Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment 1-gen-2022 Marchesi, I.; Fais, M.; Fiorentino, F. P.; Bordoni, V.; Sanna, L.; Zoroddu, S.; Bagella, L.
Design, synthesis, and biological screening of a series of 4′-fluoro-benzotriazole-acrylonitrile derivatives as microtubule-destabilising agents (MDAs) 1-gen-2022 Riu, Federico; Ibba, Roberta; Zoroddu, Stefano; Sestito, Simona; Lai, Michele; Piras, Sandra; Sanna, Luca; Bordoni, Valentina; Bagella, Luigi Marco; Carta, Antonio
Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity 1-gen-2022 Zoroddu, S.; Corona, P.; Sanna, L.; Borghi, F.; Bordoni, V.; Asproni, B.; Pinna, G. A.; Bagella, L.; Murineddu, G.
PRC2: an epigenetic multiprotein complex with a key role in the development of rhabdomyosarcoma carcinogenesis 1-gen-2021 Zoroddu, S.; Marchesi, I.; Bagella, L.
Silver nanoparticles derived by artemisia arborescens reveal anticancer and apoptosis-inducing effects 1-gen-2021 Bordoni, V.; Sanna, L.; Lyu, W.; Avitabile, E.; Zoroddu, S.; Medici, S.; Kelvin, D. J.; Bagella, L.